TCR targeting hematopoiesis to cure leukemia.
作者信息
Falkenburg J H Frederik, Heemskerk Mirjam H M
机构信息
Leiden University Medical Center.
出版信息
Blood. 2024 Sep 5;144(10):1031-1033. doi: 10.1182/blood.2024024972.
PMID:39235801
Abstract
摘要
相似文献
1
TCR targeting hematopoiesis to cure leukemia.靶向造血作用的T细胞受体用于治疗白血病。
Blood. 2024 Sep 5;144(10):1031-1033. doi: 10.1182/blood.2024024972.
2
Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice.嵌合抗原受体 T 细胞过继免疫治疗前的抗 B 细胞抗体耗竭有助于清除免疫活性小鼠中的白血病。
Blood. 2009 Dec 24;114(27):5454-63. doi: 10.1182/blood-2009-08-232967. Epub 2009 Oct 30.
3
Perspective: assembly line immunotherapy.观点：流水线式免疫疗法。
Nature. 2013 Jun 27;498(7455):S17. doi: 10.1038/498S17a.
4
Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform.使用改良的睡美人转座子平台，通过嵌合抗原受体修饰的淋巴细胞对急性白血病进行免疫治疗。
Oncotarget. 2016 Aug 9;7(32):51581-51597. doi: 10.18632/oncotarget.9955.
5
Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells.WT1-TCR基因转导的人T细胞消除NOD/SCID小鼠体内的人白血病细胞。
Blood. 2005 Nov 1;106(9):3062-7. doi: 10.1182/blood-2005-01-0146. Epub 2005 Jul 14.
6
Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia.经基因工程改造的具有白血病脂质特异性 TCR 的人 T 细胞可实现对表达 CD1c 的白血病的供体非限制性识别。
Nat Commun. 2021 Aug 11;12(1):4844. doi: 10.1038/s41467-021-25223-0.
7
Emerging applications of gene edited T cells for the treatment of leukemia.基因编辑T细胞在白血病治疗中的新兴应用。
Expert Rev Hematol. 2017 Sep;10(9):753-755. doi: 10.1080/17474086.2017.1350575. Epub 2017 Jul 25.
8
Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors.嵌合抗原受体重定向T细胞的过继性治疗：靶向实体瘤的挑战
Immunotherapy. 2015;7(5):535-44. doi: 10.2217/imt.15.15.
9
Chimeric antigen receptor T cells: power tools to wipe out leukemia and lymphoma.嵌合抗原受体T细胞：消灭白血病和淋巴瘤的有力工具。
Expert Rev Hematol. 2015 Aug;8(4):383-5. doi: 10.1586/17474086.2015.1043884. Epub 2015 May 6.
10
Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.激活的不变自然杀伤 T 细胞以 CD1d 非依赖性的方式直接识别白血病细胞。
Cancer Sci. 2020 Jul;111(7):2223-2233. doi: 10.1111/cas.14428. Epub 2020 Jun 19.
引用本文的文献
1
Immunotherapy using CAR T cells shows promising long-term outcomes for people with the blood cancer myeloma.使用嵌合抗原受体（CAR）T细胞的免疫疗法对患有血癌骨髓瘤的患者显示出有希望的长期疗效。
Nature. 2025 Sep;645(8079):44-45. doi: 10.1038/d41586-025-02592-w.
2
Current Anti-Myeloma Chimeric Antigen Receptor-T Cells: Novel Targets and Methods.当前抗骨髓瘤嵌合抗原受体T细胞：新靶点与新方法
Balkan Med J. 2025 Jul 1;42(4):301-310. doi: 10.4274/balkanmedj.galenos.2025.2025-4-25.
Zotero 插件